Inventor · disambiguated record
Vanitha Ramakrishnan
Also filed as: RAMAKRISHNAN VANITHA
20 granted patents·7 pending applications·295 citations·filing 1994–2024
95Inventor score
Files withFACET BIOTECH CORP6PDL BIOPHARMA INC6HARPOON THERAPEUTICS INC4ABBOTT BIOTHERAPEUTICS CORP2COR THERAPEUTICS INC2
Top patents by PatentIndex Score
27 records- 0198US9708412B2Trispecific binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2016·Granted Jul 18, 2017·66 cites·12 claims
- 0295US7399469B2Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancerPDL BIOPHARMA INC·Filed 2005·Granted Jul 15, 2008·22 cites·10 claims
- 0392US10954311B2Trispecific binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2017·Granted Mar 23, 2021·9 cites·21 claims
- 0491US7674883B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Mar 9, 2010·6 cites·14 claims
- 0591US7662384B2Use of anti-α5β1 antibodies to inhibit cancer cell proliferationFACET BIOTECH CORP·Filed 2005·Granted Feb 16, 2010·21 cites·13 claims
- 0691US7288248B2Antibodies against cancer antigen TMEFF2 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 30, 2007·27 cites·7 claims
- 0788US7285268B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisPDL BIOPHARMA INC·Filed 2004·Granted Oct 23, 2007·18 cites·10 claims
- 0888US7276589B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisPDL BIOPHARMA INC·Filed 2003·Granted Oct 2, 2007·23 cites·9 claims
- 0985US2025197526A1Trispecific binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1084US7824678B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Nov 2, 2010·4 cites·9 claims
- 1183US5817310AInhibitory immunoglobulin polypeptides to human PDGF beta receptorCOR THERAPEUTICS INC·Filed 1994·Granted Oct 6, 1998·72 cites·44 claims
- 1281US8017116B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisABBOTT BIOTHERAPEUTICS CORP·Filed 2007·Granted Sep 13, 2011·3 cites·4 claims
- 1381US7785816B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Aug 31, 2010·2 cites·4 claims
- 1475US12084518B2Trispecific binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·0 cites·21 claims
- 1572US7060271B2Inhibitory immunoglobulin polypeptides to human PDGF beta receptorMILLENNIUM PHARM INC·Filed 1998·Granted Jun 13, 2006·21 cites·19 claims
- 1666US8309084B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisRAMAKRISHNAN VANITHA·Filed 2011·Granted Nov 13, 2012·1 cites·6 claims
- 1764US7879987B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisFACET BIOTECH CORP·Filed 2007·Granted Feb 1, 2011·0 cites·11 claims
- 1864US7776585B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisFACET BIOTECH CORP·Filed 2007·Granted Aug 17, 2010·0 cites·11 claims
- 1963US7897148B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisABBOTT BIOTHERAPEUTICS CORP·Filed 2007·Granted Mar 1, 2011·0 cites·8 claims
- 2058US2008260740A1Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of CancerPDL BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 2158US2010291111A1Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell ProliferationFACET BIOTECH·Filed 2009·Application pending·0 cites
- 2255US2003228307A1Inhibitory immunoglobulin polypeptides to human PDGF beta receptorCOR THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 2352US8257708B2Antibodies against cancer antigen TMEFF2 and uses thereofBHASKAR VINAY·Filed 2010·Granted Sep 4, 2012·0 cites·21 claims
- 2450US6953874B2Transgenic animals having a modified glycoprotein V geneMILLENNIUM PHARM INC·Filed 2001·Granted Oct 11, 2005·0 cites·11 claims
- 2548US2008181903A1Conjugate of natriuretic peptide and antibody constant regionPDL BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 2644US2009041767A1Pharmaceutical combinationsRAMAKRISHNAN VANITHA·Filed 2008·Application pending·0 cites
- 2738US2006008415A1Stable liquid and lyophilized formulation of proteinsPROTEIN DESIGN LABS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vanitha Ramakrishnan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →